Stay updated on AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Sign up to get notified when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.

Latest updates to the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page
- Check4 days agoChange DetectedAdded 'Small cell lung carcinoma' to the Conditions list in the study details.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. The study details content and eligibility information appear unchanged.SummaryDifference0.0%

- Check25 days agoChange DetectedFooter now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded site revision banner "Revision: v3.4.2" and removed the previous "Revision: v3.4.1" banner (along with the funding-status notice). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center operations was added, and the page version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check68 days agoChange DetectedAdded a glossary toggle and small UI changes, including capitalization tweaks and a new revision tag (Revision: v3.4.0). No changes to study content, eligibility criteria, or key results were observed.SummaryDifference0.2%

Stay in the know with updates to AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.